Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with one of the following cancers at an early to intermediate stage: breast cancer (stage I–III), colorectal cancer (stage I–III), sarcoma (stage I–III), Hodgkin or non-Hodgkin lymphoma (stage I–III), or testicular cancer (stage I–II)
- People whose cancer treatment was aimed at curing the disease, and who have been off active treatment for at least three months (hormone/endocrine therapy or oral targeted therapies taken to prevent the cancer coming back are allowed)
- People who are between one and five years from their original cancer diagnosis
- People who are able to speak and read English
- People who are able to give informed consent (meaning they can understand and agree to take part in the study)
Who may not be able to join:
- People who have moderate or severe difficulties with thinking, memory, or understanding
- People who have a severe, untreated mental health condition (such as schizophrenia or a substance use disorder) that could affect their ability to meaningfully consent to or participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 919-416-3473
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pain severity and interference as measured by Brief Pain Inventory; Fatigue as measured by PROMIS Fatigue Scale; Emotional distress as measured by PROMIS Depression Short Form; Emotional distress as measured by PROMIS Anxiety Short Form; Symptom interference as measured by MD Anderson Symptom Inventory (MDASI) Symptom Interference; Health care engagement as measured by Patient Participation Questionnaire; Patient self-assessment of communication competency with health care providers as measured by Medical Communication Competence Scale (MCCS) patient subscale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.